PAWC
LABU icon

P.A.W. Capital’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

P.A.W. Capital’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,500
Closed -$202K – 57
2022
Q2 		$202K Buy
+1,500
New +$255K 0.29% 54

Other funds holding LABU

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
AIP
Ahrens Investment Partners Lafayette, Louisiana $202M AUM 3.91% 1-Year Est. Return
SW
SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Belvedere Trading
Belvedere Trading Chicago, Illinois $84.4B AUM 52.68% 1-Year Est. Return
IMC Chicago
IMC Chicago Chicago, Illinois $278B AUM 44.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RCM
Requisite Capital Management Dallas, Texas $537M AUM 12.29% 1-Year Est. Return

P.A.W. Capital's LABU Position: Q3 2022 in Review

P.A.W. Capital sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q3 2022, closing a stake of 1,500 shares — an estimated $202K sold.

P.A.W. Capital first reported a position in LABU in Q2 2022 and held it in 1 quarter. The position peaked at $202K in Q2 2022. 47 funds tracked by Wall St. Rank hold LABU as of Q3 2022.

  • P.A.W. Capital reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q3 2022 after selling out during the quarter.
  • P.A.W. Capital sold 1,500 Direxion Daily S&P Biotech Bull 3X ETF shares in Q3 2022, an estimated $202K.
  • P.A.W. Capital first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q2 2022 and held it in 1 quarter.
  • P.A.W. Capital's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $202K in Q2 2022.
  • 47 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q3 2022.

Based on P.A.W. Capital's 13F filing for Q3 2022, filed 1 Nov 2022.